Poor removal of tedizolid during continuous hemodiafiltration: experiments using an in vitro continuous hemodiafiltration model

Poor removal of tedizolid during continuous hemodiafiltration: experiments using an in vitro continuous hemodiafiltration model

Abstract Background Tedizolid is an oxazolidinone anti-MRSA drug with included in the National Health Insurance Drug Price List in 2018. The effect of hemodialysis on tedizolid phosphate concentrations has been reported; pre-dialysis concentrations decreased by 10% compared to post- dialysis concent...

Full description

Bibliographic Details
Main Authors: Satoshi Yoshikawa, Shinichi Yoshikawa, Akira Sato, Tsukasa Matsumoto
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Tedizolid
Continuous hemodiafiltration
Methicillin-resistant Staphylococcus aureus
Online Access:https://doi.org/10.1186/s40780-023-00307-9

Similar Items

Similar Items